KLRS · Kalaris Therapeutics, Inc.
$4.10
+0.02 (+0.49%)
At close · Aug 27
Market Cap
$97.60M
Shares
23.80M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Andrew Oxtoby | President and Chief Executive Officer | $2,569,115 |
| Matthew Feinsod | Chief Medical Officer | $1,673,771 |
| Brett Hagen | Chief Accounting Officer and AlloVir’s former Chief Accounting Officer | $1,439,174 |
| Vikas Sinha | AlloVir’s Former Chief Executive Officer, President and Chief Financial Officer | $1,100,954 |
| Matthew Gall | Former Chief Financial Officer | $1,064,607 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Diana Brainard | AlloVir’s Former Chief Executive Officer | $3,028,669 |
| Andrew Oxtoby | Current President and Chief Executive Officer | $1,965,153 |
| Jeffrey Nau | Former Chief Operating Officer | $937,949 |
| Brett Hagen | AlloVir’s Former Chief Accounting Officer and our Current Chief Accounting Officer | $796,311 |
| Edward Miller | AlloVir’s Former General Counsel and Secretary | $645,693 |
| Vikas Sinha | AlloVir’s Former Chief Executive Officer, President and Chief Financial Officer | $544,400 |
| Kourous Rezaei | Former President | $445,967 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Diana Brainard | AlloVir’s Former Chief Executive Officer | $6,056,943 |
| Vikas Sinha | AlloVir’s Former Chief Executive Officer, President and Chief Financial Officer | $2,940,669 |
| Edward Miller | AlloVir’s Former General Counsel and Secretary | $1,887,870 |
| Kourous Rezaei | Former President | $675,000 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Diana Brainard | Chief Executive Officer | $9,205,379 |
| Vikas Sinha | President and Chief Financial Officer | $2,904,162 |
| Jeroen van Beek | Former Chief Commercial Officer | $1,509,654 |
| Edward Miller | General Counsel and Secretary | $1,479,295 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Diana Brainard | Chief Executive Officer | $15,136,121 |
| Vikas Sinha | President and Chief Financial Officer | $6,622,996 |
| Agustin Melian | Former Chief Medical Officer | $5,830,095 |
| Jeroen van Beek | Former Chief Commercial Officer | $4,172,849 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David Hallal | Chairman and Former Chief Executive Office r | $15,258,586 |
| Ercem Atillasoy | Chief Regulatory andSafety Officer | $6,918,172 |
| Vikas Sinha | President and Chief Financial Officer | $6,320,540 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| David Hallal | Chief Executive Officerand Chairman | $3,565,110 |
| Vikas Sinha | President and ChiefFinancial Officer | $1,629,646 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Liisa Bayko | Chief Financial Officer and Treasurer | Appointed | 2026-07-20 |
| Laurie Keating | member of the Board | Appointed | 2026-07-06 |
| Morana Jovan-Embiricos, Ph.D. | member of the Company's board of directors | Resigned | 2026-07-06 |
| Matthew Gall | Chief Financial Officer | Resigned | 2026-04-10 |
| Matthew Gall | Chief Financial Officer and Treasurer | Appointed | 2025-11-03 |
| Leone Patterson | Chair of the Audit Committee of the Board | Appointed | 2025-04-04 |
| Leone Patterson | member of the Board | Appointed | 2025-04-04 |
| Jeffrey Nau | Chief Operating Officer | Resigned | 2025-03-18 |
| Matthew Feinsod, MD | Chief Medical Officer ("CMO") | Appointed | 2025-03-18 |
| Matthew Feinsod | Chief Medical Officer | Appointed | 2025-03-18 |
| Brett Hagen | principal financial officer and principal accounting officer | Appointed | 2025-03-18 |
| Vikas Sinha | Chief Financial Officer | Resigned | 2025-03-18 |
| Edward Miller | General Counsel and Secretary | Resigned | 2025-03-18 |
| Andrew Oxtoby | Chief Executive Officer and principal executive officer | Appointed | 2025-03-18 |
| Vikas Sinha | Chief Executive Officer | Resigned | 2025-03-18 |
| Matthew Feinsod | Chief Medical Officer | Appointed | 2025-03-18 |
| Andrew Oxtoby | Chief Executive Officer and principal executive officer | Appointed | 2025-03-18 |
| Brett Hagen | principal financial officer and principal accounting officer | Appointed | 2025-03-18 |
| Edward Miller | General Counsel and Secretary | Resigned | 2025-03-18 |
| Vikas Sinha | Chief Financial Officer | Resigned | 2025-03-18 |
| Vikas Sinha | principal accounting officer | Resigned | 2025-03-18 |
| David Hallal | Chair of the Board | Appointed | 2025-03-18 |
| Vikas Sinha | Chief Executive Officer | Resigned | 2025-03-18 |
| Napoleone Ferrara | Board | Appointed | 2025-03-18 |
| Samir Patel | Board | Appointed | 2025-03-18 |
Key facts
CIK
1754068
CUSIP
482929106
13F (30d)
55 filings
55 filers
Visit website
Investor relations